zidovudine has been researched along with Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kidd, ME; Modica-Napolitano, JS; Nalbandian, A; Nalbandian, R; Nguyen, CC | 1 |
| Chandrasekaran, B; Duch, DS; Kute, TE | 1 |
| Wyngaarden, JB | 1 |
3 other study(ies) available for zidovudine and Carcinoma
| Article | Year |
|---|---|
The selective in vitro cytotoxicity of carcinoma cells by AZT is enhanced by concurrent treatment with delocalized lipophilic cations.
Topics: Adenosine Triphosphate; Carcinoma; Cations; Cell Survival; Colony-Forming Units Assay; Humans; Male; Pyridines; Thiazoles; Thymidine; Tumor Cells, Cultured; Zidovudine | 2003 |
Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Cell Survival; Colonic Neoplasms; Computer Simulation; DNA, Neoplasm; Drug Synergism; Flow Cytometry; Fluorouracil; Humans; Leukemia; Melanoma; Methotrexate; Pancreatic Neoplasms; S Phase; Tumor Cells, Cultured; Zidovudine | 1995 |
From the National Institutes of Health.
Topics: Acquired Immunodeficiency Syndrome; Carcinoma; Colorectal Neoplasms; Dipyridamole; Humans; Interferon Type I; Zidovudine | 1989 |